Performance Shipping Inc. Announces Filing of 2023 Annual Report on Form 20-F
ATHENS, Greece, March 28, 2024 (GLOBE NEWSWIRE) — Performance Shipping Inc. (NASDAQ: PSHG), (“we” or the “Company”), a global shipping […]
Urbanfund Corp. Announces Loan to Shareholder
TORONTO, March 28, 2024 (GLOBE NEWSWIRE) — Urbanfund Corp. (TSX-V: UFC) (“Urbanfund” or the “Company”), announces that it entered into […]
First Bank Announces First Quarter 2024 Earnings Conference Call
HAMILTON, N.J., March 28, 2024 (GLOBE NEWSWIRE) — First Bank (Nasdaq Global Market: FRBA) invites participation in a conference call […]
Mayfair Gold Receives Shareholder Meeting Requisition
MATHESON, Ontario, March 28, 2024 (GLOBE NEWSWIRE) — Mayfair Gold Corp. (“Mayfair” or the “Company”) (TSX-V: MFG; OTCQB: MFGCF) today […]
German American names Mary Moorhouse Chief Risk Officer
JASPER, Ind., March 28, 2024 (GLOBE NEWSWIRE) — German American Bancorp, Inc. (Nasdaq: GABC) announced today that Mary Moorhouse has […]
Dorney Park & Wildwater Kingdom to Host Iron Menace Ride for a Cause Event to Benefit Eagles Autism Foundation
Allentown, PA, March 28, 2024 (GLOBE NEWSWIRE) — March 27, 2024 – Dorney Park & Wildwater Kingdom will make history […]
TSX News -
For Fifth Consecutive Year, ISC Earns the Globe and Mail’s 2024 Women Lead Here Benchmark for Executive Gender Diversity
REGINA, Saskatchewan, March 28, 2024 (GLOBE NEWSWIRE) — Information Services Corporation (TSX:ISV) (“ISC” or the “Company”) is pleased to announce […]
Highest Performances Announces Acquisition of an AI Humanoid Robot Hardware Manufacturer
GUANGZHOU, China, March 28, 2024 (GLOBE NEWSWIRE) — Highest Performances Holdings Inc. (NASDAQ: HPH) (“HPH” or the “Company”), a leading […]
Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
CHATHAM, N.J., March 28, 2024 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical […]
FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
HOUSTON, March 28, 2024 (GLOBE NEWSWIRE) — FibroBiologics (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and […]
